The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 142.00
Ask: 145.00
Change: -3.25 (-2.24%)
Spread: 3.00 (2.113%)
Open: 146.00
High: 146.00
Low: 142.00
Prev. Close: 145.25
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 May 2022 07:00

RNS Number : 1891L
Redcentric PLC
12 May 2022
 

DRAFT

Redcentric plc

("Redcentric" or the "Company")

Directorate Change

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is pleased to announce that Alan Aubrey will join the board of directors of the Company (the "Board") as non-executive director. Alan's appointment will be effective from the announcement of the Company's preliminary results for the financial year ended 31 March 2022, expected to be on 21 July 2022. The Company also announces that Jon Kempster, current chair of the Company's Audit Committee, intends to step down from the Board on announcement of the Company's preliminary results. Alan will take over as chair of the Company's Audit Committee and Senior Independent Director from the same date and also be a member of the Company's Remuneration and Nomination Committees.

Alan is an experienced executive and non-executive director, having been CEO of IP Group plc from 2006 to 2021 and having served as non-executive chair of Ceres Power Holdings plc and Proactis Holdings plc and non-executive director in Avacta Group plc. Alan has also served on the boards of several, large private companies including Oxford Nanopore, Ceres Power and Oxford Sciences Innovation plc and previously served as a non-executive director and chaired the audit committee of the Department of Business, Innovation, University and Skills ('DIUS', now the Department for Business, Energy & Industrial Strategy 'BEIS') of the UK government. Alan is a qualified chartered accountant.

Nick Bate, non-executive chair, commented:

"I am delighted that Alan will be joining the Board of Redcentric and we all look forward to working with him. His breadth and depth of skills and experience will be of huge value to the Board as well as the audit committee, and his market knowledge will be of great benefit to Redcentric."

 

As required under Schedule Two, paragraph (g) of the AIM Rules for Companies, further disclosures on Mr Aubrey are as follows:

Mr Alan John Aubrey, aged 61, has held the following directorships and/or partnerships in the past five years:

Current directorships and/or partnerships:

· IP2IPO Services Limited

· Trellix Limited

· Rio Al Limited

· EUREKA! THE NATIONAL CHILDREN'S MUSEUM.

Past directorships and/or partnerships:

· Top Technology Ventures Limited

· IP Assist Services Limited

· IP2IPO Asia-Pacific Limited

· IP2IPO Innovations Limited

· IP2IPO Limited

· LifeUK (IP2IPO) Limited

· IP Venture (Scotland) Limited

· IP Industry Partners Limited

· IP2IPO ANZ Carry Limited

· Avacta Group Plc

· IP Group Plc

· MOBILIOn Inc

· Oxford Nanopore Technologies Plc

· IP2IPO Guarantee Limited

· Oxford Science Enterprises Plc

· IP2IPO Management VI Limited

· Proactis Holdings Plc

· IP2IPO Management V Limited

· Ceres Power Intermediate Holdings Limited

· IP2IPO (Europe) Limited

· Ceres Power Holdings Plc

· IP2IPO Management IV Limited

· North East Technology (GP) Limited

· IP Venture Fund (GP) Limited

· Touchstone Innovations Limited

· IP2IPO Management II Limited

· IP2IPO Company Maker Limited

· IP2IPO Management Limited

· IP2IPO US Partners Limited

· Innovations Limited Partner Ltd

· IP2IPO Americas Limited

· Touchstone Innovations Investments Limited

 

Mr Aubrey holds 8,257 ordinary shares representing 0.005% of the total voting rights in the Company.

There is no further information on Mr Aubrey required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

finnCap Ltd - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKDBKKBKBQPD
Date   Source Headline
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.